Clinical review report: Mifepristone and misoprostol (Mifegymiso)
The objective of this review is to perform a systematic review of the beneficial and harmful effects of a single oral dose of mifepristone 200 mg and a single buccal dose of misoprostol 800 mcg (four 200 mcg tablets) administered in a sequential regimen for the medical termination of a developing in...
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2017, May 2017
|
| Series: | CADTH common drug review
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | The objective of this review is to perform a systematic review of the beneficial and harmful effects of a single oral dose of mifepristone 200 mg and a single buccal dose of misoprostol 800 mcg (four 200 mcg tablets) administered in a sequential regimen for the medical termination of a developing intrauterine pregnancy in women of child-bearing age |
|---|---|
| Physical Description: | 1 PDF file (viii, 62 pages) illustrations |